Retatrutide is a newly discovered substance that shows promise as a treatment for type 2 diabetes. It functions as a activator of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://gretauapb746204.smblogsites.com/39185456/dulaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes